| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4026129 | Ophthalmology | 2014 | 7 Pages |
Abstract
After PBRT, metastatic and survival rates are significantly better for juvenile than for adult patients with UM. Clinically, juvenile and adult eyes react similarly to PBRT, with patients having a comparable eye retention probability and maintaining a useful level of vision in most cases. This is the largest case-control study of proton therapy in juvenile eyes to date and further validates PBRT as an appropriate conservative treatment for UM in patients younger than 21 years.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Aleksandra MD, Ciara PhD, Ann MD, Gudrun MD, Leonidas MD,